These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16984795)

  • 21. Personalized medicine prompts push to redesign clinical trials.
    Singer E
    Nat Med; 2005 May; 11(5):462. PubMed ID: 15875041
    [No Abstract]   [Full Text] [Related]  

  • 22. Human genetic variation and personalized medicine.
    Agrawal S; Khan F
    Indian J Physiol Pharmacol; 2007; 51(1):7-28. PubMed ID: 17877289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of genotype-guided cancer therapy in solid tumors.
    Patel JN
    Pharmacogenomics; 2014 Jan; 15(1):79-93. PubMed ID: 24329193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. State and federal legislation in personalized medicine.
    Raich T; Irwin J
    MLO Med Lab Obs; 2007 Aug; 39(8):48. PubMed ID: 17867420
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacogenomics and personalized medicine--a global reality check.
    Wong SH
    Clin Chem Lab Med; 2007; 45(7):799-800. PubMed ID: 17617018
    [No Abstract]   [Full Text] [Related]  

  • 26. Personalized medicine: building the GPS to take us there.
    Ratain MJ
    Clin Pharmacol Ther; 2007 Mar; 81(3):321-2. PubMed ID: 17339859
    [No Abstract]   [Full Text] [Related]  

  • 27. [Genetic variations affect drug safety and efficacy].
    Harmsze AM; Deneer VH; Maitland-van der Zee AH; de Boer A; Klungel OH
    Ned Tijdschr Geneeskd; 2010; 154():A1503. PubMed ID: 20699026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The promise and challenges of personalized medicine for eye diseases.
    McCarty CA
    Clin Exp Ophthalmol; 2004 Jun; 32(3):236-7. PubMed ID: 15180832
    [No Abstract]   [Full Text] [Related]  

  • 29. Personalized medicine complicates medical decision-making.
    Morrow T
    Manag Care; 2008 Feb; 17(2):59-60. PubMed ID: 18361260
    [No Abstract]   [Full Text] [Related]  

  • 30. The conundrum of personalized cancer management, drug development, and economics.
    DeNardo GL
    Cancer Biother Radiopharm; 2007 Dec; 22(6):719-21. PubMed ID: 18158762
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacogenetics and the concept of individualized medicine.
    Shastry BS
    Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular imaging and personalized medicine: an uncertain future.
    Nunn AD
    Cancer Biother Radiopharm; 2007 Dec; 22(6):722-39. PubMed ID: 18158763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Personalized medicine: the translation of genetic knowledge to eye care.
    MacDonald IM
    Can J Ophthalmol; 2008 Feb; 43(1):15-7. PubMed ID: 18204502
    [No Abstract]   [Full Text] [Related]  

  • 34. Therapeutic drug monitoring as a component of personalized medicine: applications in pediatric drug development.
    Momper JD; Wagner JA
    Clin Pharmacol Ther; 2014 Feb; 95(2):138-40. PubMed ID: 24253660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic phenotype prediction from genotyping data: a bottleneck for the implementation of pharmacogenetics in drug development and clinical practice.
    LLerena A; Peñas-Lledó EM
    Drug Metab Pers Ther; 2015 Sep; 30(3):143-5. PubMed ID: 26353178
    [No Abstract]   [Full Text] [Related]  

  • 36. [II. Pharmacogenetics--the future of modern pharmacology and genetics].
    Czerska K; Bal J
    Med Wieku Rozwoj; 2004; 8(4 Pt 1):967-91. PubMed ID: 15951616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenomics. Going from genome to pill.
    Service RF
    Science; 2005 Jun; 308(5730):1858-60. PubMed ID: 15976283
    [No Abstract]   [Full Text] [Related]  

  • 38. Progress toward personalized medicine for age-related macular degeneration.
    Moroi SE; Heckenlively JR
    Ophthalmology; 2008 Jun; 115(6):925-6. PubMed ID: 18519068
    [No Abstract]   [Full Text] [Related]  

  • 39. "Personalised" drug therapy could be near.
    Larkin M
    Lancet; 1998 Jun; 351(9120):1937. PubMed ID: 9654273
    [No Abstract]   [Full Text] [Related]  

  • 40. Implications of pharmacogenomics for drug development and clinical practice.
    Ginsburg GS; Konstance RP; Allsbrook JS; Schulman KA
    Arch Intern Med; 2005 Nov; 165(20):2331-6. PubMed ID: 16287761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.